Skip to main content
Top
Published in: Translational Behavioral Medicine 2/2017

01-06-2017 | Case Study

The healthy living partnerships to prevent diabetes and the diabetes prevention program: a comparison of year 1 and 2 intervention results

Authors: Mara Z. Vitolins, DrPH, MPH, RDN, Scott P. Isom, MS, Caroline S. Blackwell, BS, Donna Kernodle, MPH, Joyce M. Sydell, MEd, Carolyn F. Pedley, MD, Jeffrey A. Katula, PhD, L. Douglas Case, PhD, David C. Goff Jr, MD, PhD

Published in: Translational Behavioral Medicine | Issue 2/2017

Login to get access

Abstract

A number of research studies have attempted to translate the behavioral lifestyle intervention delivered in the Diabetes Prevention Program (DPP). To compare the active interventions of two trials, Diabetes Prevention Program DPP and Healthy Living Partnerships to Prevent Diabetes (HELP PD), after 1 and 2 years of intervention. DPP included 3234 adults with prediabetes randomized to intensive lifestyle intervention, metformin, troglitazone, or placebo. The lifestyle intervention, professionally delivered to individuals in a clinical setting, focused on diet and increased physical activity. HELP PD, a community-based translation of DPP, included 301 adults randomized to receive intensive lifestyle intervention or enhanced usual care. Mean weight-losses at 1 year (6.9 kg in DPP, 6.4 kg in HELP PD) and 2 years (5.5 kg in DPP, 4.4 kg in HELP PD) were similar across studies. Reductions in glucose were also similar across studies at both time points (5.2 mg/dL in DPP and 4.1 mg/dL in HELP PD at 1 year; 1.8 mg/dL and 1.6 mg/dL at 2 years). HELP PD participants achieved larger reductions in triglycerides at 1 and 2 years (38.4 mg/dL and 34.9 mg/dL, respectively) than DPP participants (24.8 mg/dL and 22.4 mg/dL). High-density lipoprotein decreased in HELP PD participants at year 1 (−0.6 mg/dL) and increased in DPP (1.2 mg/dL) but there were no significant differences in year 2. HELP PD, a community model for diabetes prevention, was similar to DPP in reducing body weight and lowering blood glucose, both important risk factors that should be controlled to reduce risk for developing type 2 diabetes.
Literature
1.
go back to reference Centers for Disease Control and Prevention (2014). National Diabetes Statistics Report: estimates of diabetes and its burden in the United States. Atlanta, GA: US Department of Health and Human Services. Centers for Disease Control and Prevention (2014). National Diabetes Statistics Report: estimates of diabetes and its burden in the United States. Atlanta, GA: US Department of Health and Human Services.
2.
go back to reference Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., & Nathan, D. M. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 346, 393–403.CrossRefPubMed Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., & Nathan, D. M. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 346, 393–403.CrossRefPubMed
3.
go back to reference Absetz, P., Valve, R., Oldenburg, B., Heinonen, H., Nissinen, A., Fogelholm, M., Ilvesmaki, V., Talja, M., & Uutela, A. (2007). Type 2 diabetes prevention in the “real world”: one-year results of the GOAL implementation trial. Diabetes Care, 30, 2465–2470.CrossRefPubMed Absetz, P., Valve, R., Oldenburg, B., Heinonen, H., Nissinen, A., Fogelholm, M., Ilvesmaki, V., Talja, M., & Uutela, A. (2007). Type 2 diabetes prevention in the “real world”: one-year results of the GOAL implementation trial. Diabetes Care, 30, 2465–2470.CrossRefPubMed
4.
go back to reference Absetz, P., Oldenburg, B., Hankonen, N., Valve, R., Heinonen, H., Nissinen, A., Fogelholm, M., Talja, M., & Uutela, A. (2009). Type 2 diabetes prevention in the real world: three-year results of the GOAL lifestyle implementation trial. Diabetes Care, 32, 1418–1420.CrossRefPubMed Absetz, P., Oldenburg, B., Hankonen, N., Valve, R., Heinonen, H., Nissinen, A., Fogelholm, M., Talja, M., & Uutela, A. (2009). Type 2 diabetes prevention in the real world: three-year results of the GOAL lifestyle implementation trial. Diabetes Care, 32, 1418–1420.CrossRefPubMed
5.
go back to reference Ackermann, R. T., Finch, E. A., Brizendine, E., Zhou, H., & Marrero, D. G. (2008). Translating the diabetes prevention program into the community. The DEPLOY pilot study. Am J Prev Med, 35, 357–363.CrossRefPubMedPubMedCentral Ackermann, R. T., Finch, E. A., Brizendine, E., Zhou, H., & Marrero, D. G. (2008). Translating the diabetes prevention program into the community. The DEPLOY pilot study. Am J Prev Med, 35, 357–363.CrossRefPubMedPubMedCentral
6.
go back to reference Ackermann, R. T., Liss, D. T., Finch, E. A., Schmidt, K. K., Hays, L. M., Marrero, D. G., & Saha, C. (2015). A randomized comparative effectiveness trial for preventing type 2 diabetes. Am J Public Health, 105, 2328–2334.CrossRefPubMedPubMedCentral Ackermann, R. T., Liss, D. T., Finch, E. A., Schmidt, K. K., Hays, L. M., Marrero, D. G., & Saha, C. (2015). A randomized comparative effectiveness trial for preventing type 2 diabetes. Am J Public Health, 105, 2328–2334.CrossRefPubMedPubMedCentral
7.
go back to reference Boltri, J. M., Davis-Smith, Y. M., Seale, J. P., Shellenberger, S., Okosun, I. S., & Cornelius, M. E. (2008). Diabetes prevention in a faith-based setting: results of translational research. J Public Health Manag Pract, 14, 29–32.CrossRefPubMed Boltri, J. M., Davis-Smith, Y. M., Seale, J. P., Shellenberger, S., Okosun, I. S., & Cornelius, M. E. (2008). Diabetes prevention in a faith-based setting: results of translational research. J Public Health Manag Pract, 14, 29–32.CrossRefPubMed
8.
go back to reference Davis-Smith, Y. M., Boltri, J. M., Seale, J. P., Shellenberger, S., Blalock, T., & Tobin, B. (2007). Implementing a diabetes prevention program in a rural African-American church. J Natl Med Assoc, 99, 440–446.PubMedPubMedCentral Davis-Smith, Y. M., Boltri, J. M., Seale, J. P., Shellenberger, S., Blalock, T., & Tobin, B. (2007). Implementing a diabetes prevention program in a rural African-American church. J Natl Med Assoc, 99, 440–446.PubMedPubMedCentral
9.
go back to reference Katula, J. A., Vitolins, M. Z., Rosenberger, E. L., Blackwell, C. S., Morgan, T. M., Lawlor, M. S., & Goff Jr., D. C. (2011). One-year results of a community-based translation of the diabetes prevention program: healthy-living partnerships to prevent diabetes (HELP PD) project. Diabetes Care, 34, 1451–1457.CrossRefPubMedPubMedCentral Katula, J. A., Vitolins, M. Z., Rosenberger, E. L., Blackwell, C. S., Morgan, T. M., Lawlor, M. S., & Goff Jr., D. C. (2011). One-year results of a community-based translation of the diabetes prevention program: healthy-living partnerships to prevent diabetes (HELP PD) project. Diabetes Care, 34, 1451–1457.CrossRefPubMedPubMedCentral
10.
go back to reference Katula, J. A., Vitolins, M. Z., Morgan, T. M., Lawlor, M. S., Blackwell, C. S., Isom, S. P., Pedley, C. F., & Goff Jr., D. C. (2013). The healthy living partnerships to prevent diabetes study: 2-year outcomes of a randomized controlled trial. Am J Prev Med, 44, S324–S332.CrossRefPubMedPubMedCentral Katula, J. A., Vitolins, M. Z., Morgan, T. M., Lawlor, M. S., Blackwell, C. S., Isom, S. P., Pedley, C. F., & Goff Jr., D. C. (2013). The healthy living partnerships to prevent diabetes study: 2-year outcomes of a randomized controlled trial. Am J Prev Med, 44, S324–S332.CrossRefPubMedPubMedCentral
11.
go back to reference Kramer, M. K., Kriska, A. M., Venditti, E. M., Miller, R. G., Brooks, M. M., Burke, L. E., Siminerio, L. M., Solano, F. X., & Orchard, T. J. (2009). Translating the diabetes prevention program: a comprehensive model for prevention training and program delivery. Am J Prev Med, 37, 505–511.CrossRefPubMed Kramer, M. K., Kriska, A. M., Venditti, E. M., Miller, R. G., Brooks, M. M., Burke, L. E., Siminerio, L. M., Solano, F. X., & Orchard, T. J. (2009). Translating the diabetes prevention program: a comprehensive model for prevention training and program delivery. Am J Prev Med, 37, 505–511.CrossRefPubMed
12.
go back to reference Whittemore, R., Melkus, G., Wagner, J., Dziura, J., Northrup, V., & Grey, M. (2009). Translating the diabetes prevention program to primary care: a pilot study. Nurs Res, 58, 2–12.CrossRefPubMedPubMedCentral Whittemore, R., Melkus, G., Wagner, J., Dziura, J., Northrup, V., & Grey, M. (2009). Translating the diabetes prevention program to primary care: a pilot study. Nurs Res, 58, 2–12.CrossRefPubMedPubMedCentral
13.
go back to reference Dunkley, A. J., Bodicoat, D. H., Greaves, C. J., Russell, C., Yates, T., Davies, M. J., & Khunti, K. (2014). Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care, 37, 922–933.CrossRefPubMed Dunkley, A. J., Bodicoat, D. H., Greaves, C. J., Russell, C., Yates, T., Davies, M. J., & Khunti, K. (2014). Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care, 37, 922–933.CrossRefPubMed
14.
go back to reference Katula, J. A., Vitolins, M. Z., Rosenberger, E. L., Blackwell, C., Espeland, M. A., Lawlor, M. S., Rejeski, W. J., & Goff, D. C. (2010). Healthy living partnerships to prevent diabetes (HELP PD): design and methods. Contemp Clin Trials, 31, 71–81.CrossRefPubMed Katula, J. A., Vitolins, M. Z., Rosenberger, E. L., Blackwell, C., Espeland, M. A., Lawlor, M. S., Rejeski, W. J., & Goff, D. C. (2010). Healthy living partnerships to prevent diabetes (HELP PD): design and methods. Contemp Clin Trials, 31, 71–81.CrossRefPubMed
15.
go back to reference The Diabetes Prevention Program (1999). Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care, 22, 623–634.CrossRef The Diabetes Prevention Program (1999). Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care, 22, 623–634.CrossRef
16.
go back to reference Wing, R. R., Hamman, R. F., Bray, G. A., et al. (2004). Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res, 12(9), 1426–1434.CrossRefPubMed Wing, R. R., Hamman, R. F., Bray, G. A., et al. (2004). Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res, 12(9), 1426–1434.CrossRefPubMed
17.
go back to reference Rubin, R. R., Fujimoto, W. Y., Marrero, D. G., Brenneman, T., Charleston, J. B., Edelstein, S. L., Fisher, E. B., Jordan, R., Knowler, W. C., Lichterman, L. C., Prince, M., & Rowe, P. M. (2002). The diabetes prevention program: recruitment methods and results. Control Clin Trials, 23, 157–171.CrossRefPubMed Rubin, R. R., Fujimoto, W. Y., Marrero, D. G., Brenneman, T., Charleston, J. B., Edelstein, S. L., Fisher, E. B., Jordan, R., Knowler, W. C., Lichterman, L. C., Prince, M., & Rowe, P. M. (2002). The diabetes prevention program: recruitment methods and results. Control Clin Trials, 23, 157–171.CrossRefPubMed
18.
go back to reference Diabetes Prevention Program (DPP) Research Group (2002). The diabetes prevention program (DPP): description of lifestyle intervention. Diabetes Care, 25, 2165–2171.CrossRef Diabetes Prevention Program (DPP) Research Group (2002). The diabetes prevention program (DPP): description of lifestyle intervention. Diabetes Care, 25, 2165–2171.CrossRef
19.
go back to reference Garfield, S. A., Malozowski, S., Chin, M. H., Venkat Narayan, K. M., Glasgow, R. E., Green, L. W., et al. (2003). Considerations for diabetes translational research in real-world settings. Diabetes Care, 26, 2670–2674.CrossRefPubMed Garfield, S. A., Malozowski, S., Chin, M. H., Venkat Narayan, K. M., Glasgow, R. E., Green, L. W., et al. (2003). Considerations for diabetes translational research in real-world settings. Diabetes Care, 26, 2670–2674.CrossRefPubMed
20.
go back to reference Herman, W. H., Brandle, M., Zhang, P., Williamson, D. F., Matulik, M. J., Ratner, R. E., Lachin, J. M., & Engelgau, M. M. (2003). Diabetes prevention program research group costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care, 26(1), 36–47.CrossRef Herman, W. H., Brandle, M., Zhang, P., Williamson, D. F., Matulik, M. J., Ratner, R. E., Lachin, J. M., & Engelgau, M. M. (2003). Diabetes prevention program research group costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care, 26(1), 36–47.CrossRef
21.
go back to reference Blackwell, C. S., Foster, K. A., Isom, S., Katula, J. A., Vitolins, M. Z., Rosenberger, E. L., & Goff Jr., D. C. (2011). Healthy living partnerships to prevent diabetes: recruitment and baseline characteristics. Contemp Clin Trials, 32, 40–49.CrossRefPubMed Blackwell, C. S., Foster, K. A., Isom, S., Katula, J. A., Vitolins, M. Z., Rosenberger, E. L., & Goff Jr., D. C. (2011). Healthy living partnerships to prevent diabetes: recruitment and baseline characteristics. Contemp Clin Trials, 32, 40–49.CrossRefPubMed
22.
go back to reference Katula, J. A., Blackwell, C. S., Rosenberger, E. L., & Goff Jr., D. C. (2011). Translating diabetes prevention programs: 1tions for dissemination and policy. N C Med J, 72, 405–408.PubMedPubMedCentral Katula, J. A., Blackwell, C. S., Rosenberger, E. L., & Goff Jr., D. C. (2011). Translating diabetes prevention programs: 1tions for dissemination and policy. N C Med J, 72, 405–408.PubMedPubMedCentral
23.
go back to reference Lawlor, M. S., Blackwell, C. S., Isom, S. P., Katula, J. A., Vitolins, M. Z., Morgan, T. M., & Goff Jr., D. C. (2013). Cost of a group translation of the diabetes prevention program: healthy living partnerships to prevent diabetes. Am J Prev Med, 44, S381–S389.CrossRefPubMed Lawlor, M. S., Blackwell, C. S., Isom, S. P., Katula, J. A., Vitolins, M. Z., Morgan, T. M., & Goff Jr., D. C. (2013). Cost of a group translation of the diabetes prevention program: healthy living partnerships to prevent diabetes. Am J Prev Med, 44, S381–S389.CrossRefPubMed
24.
go back to reference Sydell, J., Kernodle, D., Blackwell, C. S., & Vitolins, M. Z. (2015). Identifying, training, and monitoring community health Workers in a Community-Based Diabetes Prevention Study. JJ Community Medicine, 1. Sydell, J., Kernodle, D., Blackwell, C. S., & Vitolins, M. Z. (2015). Identifying, training, and monitoring community health Workers in a Community-Based Diabetes Prevention Study. JJ Community Medicine, 1.
25.
go back to reference McCraw, E. F., Peterson, M. J., Yarnell, G., & Ashmore, J. (1968). Autoregulation of glucose in the isolated perfused rat liver. Adv Enzym Regul, 6, 57–65.CrossRef McCraw, E. F., Peterson, M. J., Yarnell, G., & Ashmore, J. (1968). Autoregulation of glucose in the isolated perfused rat liver. Adv Enzym Regul, 6, 57–65.CrossRef
26.
go back to reference Warnick, G. R. (1986). Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol, 129, 101–123.CrossRefPubMed Warnick, G. R. (1986). Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol, 129, 101–123.CrossRefPubMed
27.
go back to reference Warnick, G. R., Mayfield, C., Benderson, J., Chen, J. S., & Albers, J. J. (1982). HDL cholesterol quantitation by phosphotungstate-Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method. Am J Clin Pathol, 78, 718–723.CrossRefPubMed Warnick, G. R., Mayfield, C., Benderson, J., Chen, J. S., & Albers, J. J. (1982). HDL cholesterol quantitation by phosphotungstate-Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method. Am J Clin Pathol, 78, 718–723.CrossRefPubMed
28.
go back to reference Ali, M. K., Echouffo-Tcheugui, J., & Williamson, D. F. (2012). How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program? Health Aff (Millwood), 31, 67–75.CrossRef Ali, M. K., Echouffo-Tcheugui, J., & Williamson, D. F. (2012). How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program? Health Aff (Millwood), 31, 67–75.CrossRef
29.
Metadata
Title
The healthy living partnerships to prevent diabetes and the diabetes prevention program: a comparison of year 1 and 2 intervention results
Authors
Mara Z. Vitolins, DrPH, MPH, RDN
Scott P. Isom, MS
Caroline S. Blackwell, BS
Donna Kernodle, MPH
Joyce M. Sydell, MEd
Carolyn F. Pedley, MD
Jeffrey A. Katula, PhD
L. Douglas Case, PhD
David C. Goff Jr, MD, PhD
Publication date
01-06-2017
Publisher
Springer US
Published in
Translational Behavioral Medicine / Issue 2/2017
Print ISSN: 1869-6716
Electronic ISSN: 1613-9860
DOI
https://doi.org/10.1007/s13142-016-0447-z

Other articles of this Issue 2/2017

Translational Behavioral Medicine 2/2017 Go to the issue